Literature DB >> 7496011

Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema.

A M Elliott1, S E Berning, M D Iseman, C A Peloquin.   

Abstract

We describe a patient with drug-resistant chronic tuberculous empyema in whom substantial differences between achievable pleural fluid and serum drug concentrations were displayed. The ratio of maximum concentration in pleural fluid to serum was especially low for rifampin (4%) but was also low for streptomycin (34%) and ofloxacin (48%). Subtherapeutic drug concentrations in the pleural fluid may have contributed to acquisition of drug resistance in this case.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7496011     DOI: 10.1016/0962-8479(95)90016-0

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  22 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 2.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient.

Authors:  Rutger Hermsen; J Barrett Deris; Terence Hwa
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

4.  The population dynamics of antimicrobial chemotherapy.

Authors:  M Lipsitch; B R Levin
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  Melanoma brain metastases: is it time to reassess the bias?

Authors:  Jaclyn C Flanigan; Lucia B Jilaveanu; Mark Faries; Mario Sznol; Stephan Ariyan; James B Yu; Jonathan P S Knisely; Veronica L Chiang; Harriet M Kluger
Journal:  Curr Probl Cancer       Date:  2011 Jul-Aug       Impact factor: 3.187

Review 6.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

7.  Isoniazid pharmacokinetics in children treated for respiratory tuberculosis.

Authors:  H S Schaaf; D P Parkin; H I Seifart; C J Werely; P B Hesseling; P D van Helden; J S Maritz; P R Donald
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

Review 8.  Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.

Authors:  Roger K Verbeeck; Gunar Günther; Dan Kibuule; Christian Hunter; Tim W Rennie
Journal:  Eur J Clin Pharmacol       Date:  2016-06-15       Impact factor: 2.953

9.  Convection shapes the trade-off between antibiotic efficacy and the selection for resistance in spatial gradients.

Authors:  Matti Gralka; Diana Fusco; Stephen Martis; Oskar Hallatschek
Journal:  Phys Biol       Date:  2017-07-19       Impact factor: 2.583

10.  Treatment of a tuberculous empyema with simultaneous oral and intrapleural antituberculosis drugs.

Authors:  Richard Long; James Barrie; Kenneth Stewart; Charles A Peloquin
Journal:  Can Respir J       Date:  2008 Jul-Aug       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.